Pharma Journalist -

AstraZeneca’s Saphnelo (anifrolumab) has been approved in the European Union as an add-on therapy for the treatment of adult patients with moderate to severe, active…
Read More...

Moderna, Inc. a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Laboratorios Farmacéuticos Rovi, S.A. (BME: ROVI), a pan-European pharmaceutical…
Read More...

Equillium, Inc. a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disorders with high unmet medical need,…
Read More...

Mirati Therapeutics, Inc. a clinical-stage targeted oncology company today announced that the U.S. Food and Drug Administration (FDA) accepted the New Drug Application (NDA) for …
Read More...

TransPerfect Life Sciences, a leading provider of services and technologies to support global clinical trials and product development for the biopharmaceutical industry, announced that…
Read More...

Pfizer Inc. and OPKO Health, Inc. announced that the European Commission has granted marketing authorization for the next-generation long-acting recombinant human growth hormone NGENLA™…
Read More...

ImmunoGen Inc. a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced a global, multi-year definitive licensing agreement…
Read More...

Kallyope, Inc., a leading biotechnology company focused on identifying and developing therapeutics involving the gut-brain axis, announced the closing of a $236 million Series D…
Read More...

Adcentrx Therapeutics a biotechnology company focused on accelerating breakthroughs in antibody drug conjugate therapeutic development, and AvantGen, a leader in the use of yeast…
Read More...

Tetra Bio-Pharma Inc. a leader in cannabinoid-derived drug discovery and development announced that it has executed a non-binding term sheet with Avicanna Inc. ("Avicanna") to assess…
Read More...